A Multiple Ascending Dose Study of Tadalafil 2018-01-08T14:47:54+00:00

Clinical Trials

July 6, 2012

A Multiple Ascending Dose Study of Tadalafil to Assess the Pharmacokinetics and Safety in a Pediatric Population with Pulmonary Arterial Hypertension

  • Start Date: 6/2012
  • End Date: Active, not recruiting
  • Design: Treatment-naive only, Open label
  • Age range (years): 6 months to 18 years
  • Type of PH
    • All PAH (Group 1 PH)
    • IPAH
    • Heritable – APAH
  • Study Duration for individual patient: 10 weeks
  • Contact: Rosemary Rizk
  • Listing on clinicaltrials.gov